FOX BIZ NEWS: Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief

Novavax 'confident' in scaling up to 100M vaccine doses by end of year: R&D chief



Maryland-based Novavax just began dosing for the Phase 1 clinical trial in Australia.